SovAI

Headlines · 1

1. Nov 5
   Potential Sciences Launches With Seed Round for Physics-Based AI Drug Discovery

   WIRED reports that British startup Potential Sciences launched on November 5 with seed funding in the tens of millions of dollars from SovAI, the UK's government AI venture fund, Twin Path Ventures and other investors; the precise amount and valuation were not disclosed. The company plans to build large-scale chemical datasets by simulating interactions from atoms up to molecules, amino acids and proteins, then use them to train AI models for identifying targeted drug candidates. Founder and CEO Hatem Helal says the goal is to make molecules that will fail clinically fail faster and to make bespoke, individually tailored medicines economical, while academics note that accurately predicting protein binding would require a marked leap forward.

   WIRED AI · 🔥 0

Experience and discussion from the community

Share my SovAI experienceAsk about SovAI